Effective Dose of Ramosetron for Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Patients

Background. Postoperative nausea and vomiting (PONV) are common adverse events with an incidence of up to 80% in high-risk patients. Ramosetron, a selective 5-HT(3) receptor antagonist, is widely used to prevent PONV. The purpose of this study was to evaluate the effective dose of ramosetron for the...

Full description

Saved in:
Bibliographic Details
Published in:Biomed Res Int
Main Authors: Lee, Seongheon, Jeong, Sinho, Kim, Joungmin, Jeong, Seongwook
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2015
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4516817/
https://ncbi.nlm.nih.gov/pubmed/26258145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/951474
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items